First COVID-19 vaccine tested on humans raises hopes for cure through its early trial results

Also, the Hyderabad-based Bharat Biotech has partnered with the US-based FluGen and University of Wisconsin Madison, for producing 300 million doses of CoroFlu, a COVID-19 vaccine which could be in human clinical trials by the fall of 2020.